Atomo HIV Self Test

/Tag:Atomo HIV Self Test

PRESS RELEASE: Mylan Extends Commitment to Fight HIV/AIDS by Partnering with Atomo Diagnostics to Expand Access to HIV Self-Testing in Low- and Middle-Income Countries

HERTFORDSHIRE, England, PITTSBURGH and SYDNEY, September 24, 2018 – Global pharmaceutical company Mylan N.V.(NASDAQ: MYL) and medical device company Atomo Diagnostics today announced a strategic partnership to commercialize CE-Marked in vitro [...]

September 24th, 2018|

Strategic Partnership Announcement: Atomo Diagnostics and Owen Mumford

Today, Atomo Diagnostics and Owen Mumford Ltd announced a strategic partnership for commercialisation of innovative HIV rapid tests in European markets Owen Mumford is a major healthcare company and device [...]

June 5th, 2018|

Atomo Diagnostics and Owen Mumford partner to introduce best-in-class HIV rapid testing in European markets

Sydney, Australia and Woodstock, England – 05 June 2018 | Atomo Diagnostics and Owen Mumford Ltd have today announced a strategic partnership for commercialisation of innovative HIV rapid tests in [...]

June 5th, 2018|

PRESS RELEASE: Expert Review Panel for Diagnostics approves Atomo HIV Self Test for procurement by Unitaid and the Global Fund

Sydney, Australia, 7 December 2017 | Atomo Diagnostics, the world leader in integrated point-of-care rapid diagnostic devices, announced today that its Atomo HIV Self Test has been confirmed as eligible [...]

December 6th, 2017|

World AIDS Day 2017: Self-testing key to improving early diagnosis of HIV

Written by CEO, John Kelly: As I read the news, on this World AIDS Day, I am heartened to see so many positive and inspiring stories about the progress being [...]

December 1st, 2017|